Desferoxamine reverses neonatal iron-induced recognition memory impairment in rats

European Journal of Pharmacology

Volumn 570, Issue 1-3, 2007, Pages 111-114

  de Lima, Maria N M ^a   Presti Torres, Juliana ^a   Caldana, Fábio ^a   Grazziotin, Manoela M ^a   Scalco, Felipe S ^a   Guimarães, Marcelo R ^a   Bromberg, Elke ^a   Franke, Silvia I R ^b   Henriques, João A P ^b   Schröder, Nadja ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Desferoxamine; Iron; Recognition memory

Indexed keywords

DEFEROXAMINE; IRON; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; IRON OVERLOAD; MALE; MEMORY DISORDER; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; TASK PERFORMANCE; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; DEFEROXAMINE; IRON; MALE; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; RATS; SIDEROPHORES;

EID: 34547849625     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.002     Document Type: Article

References (39)

1. Anderson G.J., and Powell L.W. Of metals, mice, and men: what animal models can teach us about body iron loading. J. Clin. Invest. 105 (2000) 1185-1186
2. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
3. Bartzokis G., and Tishler T.A. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell. Mol. Biol. (Noisy-le-grand) 46 (2000) 821-833
4. Bartzokis G., Cummings J., Perlman S., Hance D.B., and Mintz J. Increased basal ganglia iron levels in Huntington disease. Arch. Neurol. 56 (1999) 569-574
5. Bartzokis G., Beckson M., Lu P.H., Nuechterlein K.H., Edwards N., and Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch. Gen. Psychiatry 58 (2001) 461-465
6. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., Huang D., Edwards N., and Mintz J. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 28 (2007) 414-423
7. Benkovic S.A., and Connor J.R. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 338 (1993) 97-113
8. Ben-Shachar D., Eshel G., Finberg J.P., and Youdim M.B. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56 (1991) 1441-1444
9. Connor J.R., Menzies S.L., St Martin S.M., and Mufson E.J. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27 (1990) 595-611
10. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., and LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65 (1995) 717-724
11. Crapper D.R., Dalton A.J., Kruck T.P., Bell M.Y., Smith W.L., Kalow W., and Andrews D.F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 338 8762 (1991) 324-326
12. Dal-Pizzol F., Klamt F., Frota Jr. M.L.C., Andrades M.E., Caregnato F.F., Vianna M.R.M., Schröder N., Quevedo J., Izquierdo I., Archer T., and Moreira J.C.F. Neonatal iron exposure induces oxidative stress in adult Wistar rats. Dev. Brain Res. 130 (2001) 109-114
13. De Lima M.N., Laranja D.C., Caldana F., Grazziotin M.M., Garcia V.A., Dal-Pizzol F., Bromberg E., and Schröder N. Selegiline protects against recognition memory impairment induced by neonatal iron treatment. Exp. Neurol. 196 (2005) 177-183
14. De Lima M.N., Polydoro M., Laranja D.C., Bonatto F., Bromberg E., Moreira J.C., Dal-Pizzol F., and Schröder N. Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur. J. Neurosci. 21 (2005) 2521-2528
15. De Lima M.N., Luft T., Roesler R., and Schröder N. Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci. Lett. 405 (2006) 142-146
16. De Lima, M.N., Dias, C.P., Presti-Torres, J., Dornelles, A., Garcia, V.A., Scalco, F.S., Guimarães, M.R., Petry, R.C., Bromberg, E., Constantino, L., Budni, P., Dal-Pizzol, F., Schröder, N., in press. Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2007.02.006.
17. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., and Marsden C.D. Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52 (1994) 1830-1836
18. Fredriksson A., Schröder N., Eriksson P., Izquierdo I., and Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol. Appl. Pharmacol. 159 (1999) 25-30
19. Fredriksson A., Schröder N., Eriksson P., Izquierdo I., and Archer T. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Dev. Brain Res. 119 (2000) 65-74
20. Freret T., Valable S., Chazalviel L., Saulnier R., Mackenzie E.T., Petit E., Bernaudin M., Boulouard M., and Schumann-Bard P. Delayed administration of desferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci. 23 (2006) 1757-1765
21. Focht S.J., Snyder B.S., Beard J.L., Van Gelder W., Williams L.R., and Connor J.R. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience 79 (1997) 255-261
22. Grabill C., Silva A.C., Smith S.S., Koretsky A.P., and Rouault T.A. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res. 971 (2003) 95-106
23. Grifiths P.D., Dobson B.R., Jones G.R., and Clarke D.T. Iron in the basal ganglia in Parkinson's disease. An in vivo study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 122 (1999) 667-673
24. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl 3 (2003) S26-S36
25. Ke Y., and Ming-Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2 (2003) 246-253
26. Lan J., and Jiang D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 104 (1997) 469-481
27. Long D.A., Ghosh K., Moore A.N., Dixon C.E., and Dash P.K. Desferoxamine improves spatial memory performance following experimental brain injury in rats. Brain Res. 717 (1996) 109-117
28. Lozoff B., and Georgieff M.K. Iron deficiency and brain development. Semin. Pediatr. Neurol. 13 (2006) 158-165
29. McCann J.C., and Ames B.N. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am. J. Clin. Nutr. 85 (2007) 931-945
30. Ong W.Y., and Farooqui A.A. Iron, neuroinflammation, and Alzheimer's disease. J. Alzheimer's Dis. 8 (2005) 183-200
31. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., Ferrer I., Arranz R., and Patino C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 153 (2006) 42-54
32. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., Sjogren M., Wallin A., Xilinas M., and Gottfries C.G. Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 12 (2001) 408-414
33. Roskams A.J., and Connor J.R. Iron, transferrin, and ferritin in the rat brain during development and aging. J. Neurochem. 63 (1994) 709-716
34. Schröder N., O'Dell S.J., and Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49 (2003) 89-96
35. Schröder N., Fredriksson A., Vianna M.R.M., Roesler R., Izquierdo I., and Archer T. Memory deficits in adult rats following postnatal iron administration. Behav. Brain Res. 124 (2001) 77-85
36. Thomas M., and Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr. Opin. Neurol. 17 (2004) 437-442
37. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5 (2004) 863-873
38. Zhang P., Land W., Lee S., Juliani J., Lefman J., Smith S.R., Germain D., Kessel M., Leapman R., Rouault T.A., and Subramaniam S. Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J. Struct. Biol. 150 (2005) 144-153
39. Youdim M.B., Stephenson G., and Ben Shachar D. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann. N. Y. Acad. Sci. 1012 (2004) 306-325